BioXcel Gets First Approval With Igalmi For Neuropsychiatric Agitation

 
• By Joseph Haas

Sublingual film product Igalmi is approved to treat agitation related to schizophrenia and bipolar disorder, but BioXcel also is targeting a bigger market opportunity in Alzheimer’s dementia.

Anxiety
BioXcel's new sublingual film can address anxiety in psychiatric patients • Source: Alamy

More from New Products

More from Scrip